Pfizer’s twice-daily weight reduction tablet joins a protracted checklist of weight problems drug flops
Pfizer’s twice-daily model of its experimental weight reduction tablet has now joined a protracted checklist of alternative scrapped weight problems medication. Pfizer’s transfer to drop two weight problems drug applicants within the remaining
